Phase I – Bioequivalence

302 trials 14 recruiting

Filter these 302 trials by condition, country, sponsor and more.

Open in Search →

A Single Dose, Fast state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (IASIS PHARMA) vs.FU… Ended

2024-517967-22-00 healthy subjects 2025-02-25
A pilot, open label, single dose, randomized, four-period, four-sequence, four-treatment crossover, comparative bioavailability study of UDC… Ended

2024-519920-26-00 UDCA causes a reduction in cholesterol saturation of th 2025-02-20
Randomised, crossover bioequivalence clinical trial of vortioxetine 20 mg film-coated tablets, after a single oral dose administration to he… Ended

2024-516497-29-00 Antidepressant 2025-02-11
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Bosutinib… Ended

2024-516489-12-00 myeloid leukemia 2025-01-31
Bioequivalence clinical trial of two formulations of vortioxetine. Ended

2024-519398-21-00 Healthy volunteers 2025-01-30
Bioequivalence of Calcifediol monohydrate 0.266 mg Soft Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-513480-37-00 No medical condition. 2025-01-28
Bioequivalence study of GP-IMP-001 with regards to reference product Ended

2024-515889-14-00 healthy volunteers 2025-01-22
Pharmacokinetic comparison of efanesoctocog alfa vs other EHL-rFVIII products in participants with severe haemophilia A Ended

2023-505801-17-00 Haemophilia A 2025-01-15
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Dextroa… Ended

2023-509874-48-00 ADHD 2025-01-09
A relative bioavailability study between a fixed dose combination product of Ibuprofen and Paracetamol vs. free combination of Ibuprofen a… Ended

2024-516423-14-00 cold and flu 2024-12-19
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Lamotrigi… Ended

2024-513106-62-00 Bipolar disorder 2024-12-16
A study to establish the bioequivalence of free acid tafamidis 61 mg capsule and tablet, and evaluate the safety and tolerability of the 61 … Ended

2024-514166-40-00 Transthyretin amyloidosis 2024-12-16
Bioequivalence clinical trial of two formulations of linagliptin/metformin. Ended

2024-516081-11-00 Healthy volunteers 2024-12-13
KF2024#1 trial: Esketamine interaction study Ended

2024-516892-34-00 healthy volunteers 2024-12-03
Bioequivalence of Metamizole Sodium 500 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions. Ended

2024-514447-29-00 No medical condition. 2024-12-02
An open label, balanced, randomized, single dose, two treatment, two period, two sequence, crossover, bioequivalence study comparing Empagli… Ended

2024-513340-28-00 Diabetes 2024-11-19
Bioequivalence clinical trial of two formulations of linagliptin/metformin Ended

2024-515076-13-00 Healthy volunteers 2024-11-19
Randomized, open-label, single-dose, two-period, cross-over, bioequivalence study comparing Linagliptin 5 mg film-coated tablets (Vipharm S.… Ended

2024-514678-35-00 Bioequivalence study in healthy volunteers under fastin 2024-11-15
Evaluation of bioequivalence of two products containing 50 mg dimenhydrinate: Dimenhydrinate 50 mg (Test) vs. Vomex A 50 mg Lösung zum Einne… Ended

2024-515170-27-00 No therapeutic indication in the current trial with hea 2024-11-15
Bioequivalence of Lisdexamfetamine dimesylate 10 mg/mL Oral Solution in Healthy Participants Under Fasting Conditions. Ended

2024-516828-33-00 No medical condition. 2024-11-15
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2024-515436-76-00 influenza 2024-11-13
A Study to Assess the Effectiveness of Different Doses of GEH200486 Injection for Contrast-enhanced Head and Neck MRI in Healthy Volunteers Ended

2024-516751-41-00 None - imaging technique 2024-11-08
Bioequivalence clinical trial of two formulations of loperamide. Ended

2024-515531-29-00 Healthy volunteers 2024-11-04
An open label, randomized, crossover, two-period, two-sequence, multiple dose study to assess the relative bioavailability of Rotigotine 4.5… Ended

2024-515841-41-00 Not applicable (submitted trial is a bioavailability st 2024-11-04